The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2 , Pages 328-332 , February 2009

Advances in basic and clinical immunology in 2008

  • Javier Chinen, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Javier Chinen, MD, PhD, Department of Pediatrics, Allergy and Immunology Section, Baylor College of Medicine, 6621 Fannin St FC 330.01, Houston, TX 77030.
  • ,
  • William T. Shearer, MD, PhD

Received 24 December 2008 ,Accepted 24 December 2008.

References 

  1. Cousins DJ, McDonald J, Lee TH. Therapeutic approaches for control of transcription factors in allergic disease. J Allergy Clin Immunol. 2008;121:803–809
  2. Chatila TA, Li N, Garcia-Lloret M, Kim HJ, Nel AE. T-cell effector pathways in allergic diseases: transcriptional mechanism and therapeutic targets. J Allergy Clin Immunol. 2008;121:812–823
  3. Hulse KE, Reefer AJ, Engelhard VH, Satinover SH, Patrie JT, Chapman AM, et al. Targeting Fel d 1 to FcgRI induces a novel variant of the TH2 response in subjects with cat allergy. J Allergy Clin Immunol. 2008;121:756–762
  4. Del Prete G, Chiumiento L, Amedel A, Piazza M, D'Ellos MM, Codolo G, et al. Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophils-activating protein. J Allergy Clin Immunol. 2008;122:908–913
  5. Kisich KO, Carspecken CW, Fieve S, Boguniewicz M, Leung DYM. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human b-defensin-3. J Allergy Clin Immunol. 2008;122:62–68
  6. Akkoc T, de Koning PJA, Barian I, Akdis M, Akdis CA. Increased activation-induced cell death of high IFN-gamma-producing Th1 cells as a mechanism of TH2 predominance in atopic diseases. J Allergy Clin Immunol. 2008;121:652–658
  7. Leb VM, Jahn-Schmid B, Schmetterer KG, Kueng HJ, Heiderer D, Neunkichner A, et al. Molecular and functional analysis of the antigen receptor of Art v 1-specific helper T lymphocytes. J Allergy Clin Immunol. 2008;121:64–71
  8. Jabara HH, Chauduri J, Dutt S, Dedeoglu F, Weng Y, Murphy MM, et al. B cell receptor cross-linking delays activation-induced cytidine deaminase induction and inhibits class switch recombination. J Allergy Clin Immunol. 2008;121:191–196
  9. Yoneyama S, Kawai K, Tsuno NH, Oraji Y, Asakage M, Tsuchiya T, et al. Epigallocatechin gallate affects human dendritic cell differentiation and maturation. J Allergy Clin Immunol. 2008;121:209–214
  10. Jakob T, Kollisch GV, Howaldt M, Bewersdorff M, Rathkolb B, Muller ML, et al. Novel mouse mutants with primary cellular immunodeficiencies generated by genome-wide mutagenesis. J Allergy Clin Immunol. 2008;121:179–184
  11. Bas M, Kirchhartz N, Hochfeld J, Tullman C, Kumpft S, Suvorava T, et al. Potential role of vasomotor effects of fibrinogen in bradykinin-induced angioedema. J Allergy Clin Immunol. 2008;121:969–975
  12. Frank MM. Hereditary angioedema. J Allergy Clin Immunol. 2008;121:S398–S401
  13. Drouet C, Desormeaux A, Robillard J, Ponard D, Bouillet L, Martin L, et al. Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. J Allergy Clin Immunol. 2008;121:429–433
  14. Shen L, Siciliano RF. Viral reservoir, residual viremia and the potential of highly active retroviral therapy to eradicate HIV infection. J Allergy Clin Immunol. 2008;122:22–28
  15. Yin L, Rodriguez C, Hou W, Potter O, Caplan MJ, Goodenow MM, et al. Antiretroviral therapy corrects HIV-1-induced expansion of CD8+CD45RA+CD27-CD11abright activated T cell. J Allergy Clin Immunol. 2008;122:166–172
  16. Foster SB, McIntosh K, Thompson B, Lu M, Yin W, Rich KC, et al. increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. J Allergy Clin Immunol. 2008;122:159–165
  17. Moir S, Fauci AS. Pathogenic mechanism of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol. 2008;122:12–19
  18. Haynes BF, Shattock RJ. Critical issues in mucosal immunity for HIV-1 vaccine development. J Allergy Clin Immunol. 2008;122:3–9
  19. Singh KK, Lieser A, Ruan PK, Fenton T, Spector SA. An age-dependent association of mannose-binding lectin-2 genetic variants on HIV1-related disease in children. J Allergy Clin Immunol. 2008;122:173–180
  20. Garcia-Laorden MI, Sole-Violan J, Rodriguez de Castro F, Aspa J, Briones ML, Garcia-Saavedra , et al. Mannose-binding lectin and mannose-binding lectin associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J Allergy Clin Immunol. 2008;122:368–374
  21. Notarangelo LD, Sorensen R. Is it necessary to identify molecular defects in primary immunodeficiency disease?. J Allergy Clin Immunol. 2008;122:1069–1073
  22. Renner ED, Rylarsdaam S, Anover-Sombke S, Rack AL, Reicherbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper IgE syndrome. J Allergy Clin Immunol. 2008;122:181–187
  23. Roifman CM, Zhang J, Atkinson A, Grunebaum E, Mandel K. Adenosine deaminase deficiency can present with features of Omenn syndrome. J Allergy Clin Immunol. 2008;121:1057–1058
  24. Grunebaum E, Bates A, Roifman CM. Omenn syndrome is associated with mutations in DNA ligase IV. J Allergy Clin Immunol. 2008;122:1219–1220
  25. Vila A, Notarangelo LD, Roifman CM. Omenn syndrome- inflammation in leaky SCID. J Allergy Clin Immunol. 2008;122:1082–1086
  26. Elhayel M, Beaucoudrey L, Pike F, Nahas SA, Feinberg J, Casanova JL, et al. Simultaneous presentation of two primary immunodeficiencies: IL12 receptor beta 1 deficiency and ataxia telangiectasia. J Allergy Clin Immunol. 2008;122:1217–1219
  27. Al-Muhsen S, Casanova JL. The genetic heterogenecity of Mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122:1043–1051
  28. Gambineri E, Peroni L, Passerini L, Bianchi L, Doglioni C, Meschi F, et al. Clinical and molecular profile of a new series of IPEX patients: inconsistent correlation between FOXP3 protein expression and disease severity. J Allergy Clin Immunol. 2008;122:1105–1112
  29. Kavadas FD, Gilliani S, Gu Y, Mazzolari E, Bates A, Pegolani E, et al. Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations. J Allergy Clin Immunol. 2008;122:1178–1184
  30. Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ, et al. Hypomorphic NEMO mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008;122:1169–1177
  31. Salt BH, Niemela JE, Pandey R, Hanson EP, Deering RQ, Quinones R, et al. IKBKG (nuclear factor kB essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function. J Allergy Clin Immunol. 2008;121:976–982
  32. Hartl D, Lehman N, Hoffman F, Jansson A, Hector A, Notheis G, et al. Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. J Allergy Clin Immunol. 2008;121:375–382
  33. DeRavin SS, Naumann N, Cowan EW, Friend J, Hilligoss D, Marquesen M, et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol. 2008;122:1097–1103
  34. Davis CM, Kancherla VS, Reddy A, Chan W, Yeh HW, Noroski LM, et al. Development of specific T cell responses to Candida and tetanus antigen in partial DiGeorge syndrome. J Allergy Clin Immunol. 2008;122:1194–1199
  35. McLean-Tooke A, Berge D, Spickett GP, Gennery AR. Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol. 2008;122:362–367
  36. Ballow M. Immunoglobulin therapy—methods of delivery. J Allergy Clin Immunol. 2008;122:1038–1039
  37. Bonagura VR, Marchlewski R, Cox A, Rosenthal DW. Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. J Allergy Clin Immunol. 2008;122:211–212
  38. Lejtenyi D, Mazer B. Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations. J Allergy Clin Immunol. 2008;121:254–255
  39. Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Brown BS, Paul ME, et al. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. J Allergy Clin Immunol. 2008;122:1185–1193
  40. Slatter MA, Brigham K, Dickinson AM, Harvey HL, Barge D, Jackson A, et al. Long term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency. J Allergy Clin Immunol. 2008;121:361–367
  41. Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol. 2008;122:1087–1096
  42. Somech R, Kavadas F, Atkinson A, Grunebaum E, Roifman CM. High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency. J Allergy Clin Immunol. 2008;122:1215–1216
  43. Pai SY, Levy O, Jabara HH, Zglickman JN, Stoler-Barak L, Sachs J, et al. Allogeneic transplantation successfully corrects immune defect, but not susceptibility to colitis, in a patient with NEMO deficiency. J Allergy Clin Immunol. 2008;122:1113–1118

 Supported in part by National Institutes of Health grants AI069441, AI036211, HD052102, RR0188, HL079533, HL72705, HL78522, and RAT003084A; the Pediatric Research and Education Fund, Baylor College of Medicine; and the David Fund, Pediatrics AIDS Fund, and Immunology Research Fund, Texas Children's Hospital.

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(08)03536-7

doi: 10.1016/j.jaci.2008.12.1113

The Journal of Allergy and Clinical Immunology
Volume 123, Issue 2 , Pages 328-332 , February 2009